MHC class I- and class II-restricted processing and presentation of microencapsulated antigens

By Men Y.   Audran R.   Thomasin C.   Eberl G.   Demotz S.   Merkle H.P.   Gander B.   Corradin G.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1047-1056

Elsevier

Access to resources Recommend Favorite

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

By Hanke T.   Blanchard T.J.   Schneider J.   Hannan C.M.   Becker M.   Gilbert S.C.   Hill A.V.S.   Smith G.L.   McMichael A.  

Vaccine, Vol. 16, Iss. 5, 1998-03 ,pp. : 439-445

Elsevier

Access to resources Recommend Favorite

Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs)

By Tarpey I.   Stacey S.N.   McIndoe A.   Davies D.H.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 230-236

Elsevier

Access to resources Recommend Favorite

Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope

By Shams H.   Poblete F.   Russmann H.   Galan J.E.   Donis R.O.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 577-585

Elsevier

Access to resources Recommend Favorite

The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation

By Oh Y.-K.   Harding C.V.   Swanson J.A.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 511-518

Elsevier

Access to resources Recommend Favorite